Page 1 | Search Results | ASH Clinical News | American Society of Hematology

Skip to Main Content

Advertisement intended for health care professionals

Close

ASH
ASH Clinical News
ASH Image Bank Open External Link
ASH News Daily
ASH-SAP
Blood Journals
Hematology
The Hematologist
International

header search

search input Search input auto suggest

filter your search

Search

Menu

About
Viewpoints
Education
Spotlight
News
Topic Compilations

Skip Nav Destination

Update search

Querybuilder input 1 Querybuilder input

Title
Author
Full Text
Abstract
Keyword
DOI

Querybuilder input 2 Querybuilder input

Title
Author
Full Text
Abstract
Keyword
DOI

Querybuilder input 3 Querybuilder input

Title
Author
Full Text
Abstract
Keyword
DOI

Querybuilder input 4 Querybuilder input

Title
Author
Full Text
Abstract
Keyword
DOI

Querybuilder input 5 Querybuilder input

Title
Author
Full Text
Abstract
Keyword
DOI

Querybuilder input 6 Querybuilder input

Title
Author
Full Text
Abstract
Keyword
DOI

NARROW

Publications

Filter by publications

ASH Clinical News (114)

Format

Filter by format

News (114)

Topics

Filter by topics

On Location (37)
Online Only (23)
Literature Scan (20)
Acute Leukemias (19)
Chronic Leukemias (16)
In a Different Vein: News From the Blood Journals Portfolio (16)
Multiple Myeloma and Plasma Disorders (14)
MDS & Myeloproliferative Neoplasms (12)
Lymphomas & Lymphoid Neoplasia (11)
In the Literature (10)

Date

Filter by date

Date range

Single date

From

To

Apply

Availability

Availability

1-20 of 114

Lara C. Pullen, PhD

1

Sort by

Sort Order Select

News

Blood Cancer Data Underscore Importance of Lowering Radiation Exposure From Imaging

Lara C. Pullen, PhD

Published: 2025

Abstract

January 2026

View News titled, Blood Cancer Data Underscore Importance of Lowering Radiation Exposure From Imaging

News

Azacitidine, Venetoclax Effective as Treatment for Acute Myeloid Leukemia

Lara C. Pullen, PhD

Published: 2025

Abstract

December 2025

View News titled, Azacitidine, Venetoclax Effective as Treatment for Acute Myeloid Leukemia

News

Early Data Indicate Ziftomenib Plus Venetoclax/Azacitidine Effective for NPM1-Mutated AML

Lara C. Pullen, PhD

Published: 2025

Abstract

December 2025

View News titled, Early Data Indicate Ziftomenib Plus Venetoclax/Azacitidine Effective for NPM1-Mutated AML

News

Inferior Survival in Black Patients with AML Is Independent of Cytogenetic Profiles

Lara C. Pullen, PhD

Published: 2025

Abstract

December 2025

View News titled, Inferior Survival in Black Patients with AML Is Independent of Cytogenetic Profiles

News

Study Offers New Insights Into Optimal Treatment for Frail Patients with Myeloma

Lara C. Pullen, PhD

Published: 2025

Abstract

December 2025

View News titled, Study Offers New Insights Into Optimal Treatment for Frail Patients with Myeloma

News

Fixed-Duration Targeted Treatment as Effective as BTK Inhibitor Therapy for CLL

Lara C. Pullen, PhD

Published: 2025

View News titled, Fixed-Duration Targeted Treatment as Effective as BTK Inhibitor Therapy for CLL

News

CLL-Frail Trial Indicates Acalabrutinib Safe, Effective for Older, Frail Patients

Lara C. Pullen, PhD

Published: 2025

Abstract

December Supplement 2025

View News titled, CLL-Frail Trial Indicates Acalabrutinib Safe, Effective for Older, Frail Patients

News

Five-Year Follow-Up of SEQUOIA Shows Zanubrutinib Effective Against Treatment-Naïve CLL

Lara C. Pullen, PhD

Published: 2025

Abstract

December Supplement 2025

View News titled, Five-Year Follow-Up of SEQUOIA Shows Zanubrutinib Effective Against Treatment-Naïve CLL

News

Zanubrutinib Plus Venetoclax Effective as Treatment for Untreated CLL/SLL

Lara C. Pullen, PhD

Published: 2025

Abstract

December Supplement 2025

View News titled, Zanubrutinib Plus Venetoclax Effective as Treatment for Untreated CLL/SLL

News

Study Shows Measurable Residual Disease Could Be Used as Guide to Treat Chronic Lymphocytic Leukemia

Lara C. Pullen, PhD

Published: 2025

Abstract

December Supplement 2025

View News titled, Study Shows Measurable Residual Disease Could Be Used as Guide to Treat Chronic Lymphocytic Leukemia

News

What Is the Best Treatment for Double-Refractory CLL?

Lara C. Pullen, PhD

Published: 2025

Abstract

December Supplement 2025

View News titled, What Is the Best Treatment for Double-Refractory CLL?

News

Sapablursen Meets Primary Endpoint for Treatment of Polycythemia Vera

Lara C. Pullen, PhD

Published: 2025

Abstract

December 2025

View News titled, Sapablursen Meets Primary Endpoint for Treatment of Polycythemia Vera

News

Community-Based Hematologists Encouraged to Foster Clinical Trial Participation

Lara C. Pullen, PhD

Published: 2025

Abstract

Mid-November 2025

View News titled, Community-Based Hematologists Encouraged to Foster Clinical Trial Participation

News

Intermediate Dose of Cytarabine as Effective as Higher Dose for Post-Induction in AML

Lara C. Pullen, PhD

Published: 2025

Abstract

October 2025

View News titled, Intermediate Dose of Cytarabine as Effective as Higher Dose for Post-Induction in AML

News

Phase IIIb Results Show Avatrombopag to Be Safe, Effective Treatment for Children With ITP

Lara C. Pullen, PhD

Published: 2025

Abstract

September 2025

View News titled, Phase IIIb Results Show Avatrombopag to Be Safe, Effective Treatment for Children With ITP

News

Use of GLP-1 Agonists in Diabetic Patients With PV, ET Reduces VTE, Mortality

Lara C. Pullen, PhD

Published: 2025

Abstract

August 2025

View News titled, Use of GLP-1 Agonists in Diabetic Patients With PV, ET Reduces VTE, Mortality

News

Half of Patients in EINSTEIN Jr. Trial Continue to Extended Anticoagulation Treatment

Lara C. Pullen, PhD

Published: 2025

Abstract

August 2025

View News titled, Half of Patients in EINSTEIN Jr. Trial Continue to Extended Anticoagulation Treatment

News

Iptacopan Increases Hemoglobin in Paroxysmal Nocturnal Hemoglobinuria

Lara C. Pullen, PhD

Published: 2025

Abstract

July 2025

View News titled, Iptacopan Increases Hemoglobin in Paroxysmal Nocturnal Hemoglobinuria

News

Subcutaneous Mosunetuzumab Could Be Administered in Community Setting to Patients With Follicular Lymphoma

Lara C. Pullen, PhD

Published: 2025

Abstract

July 2025

View News titled, Subcutaneous Mosunetuzumab Could Be Administered in Community Setting to Patients With Follicular Lymphoma

News

Phase II Results Point Toward a New Era in Treating Acute Myeloid Leukemia

Lara C. Pullen, PhD

Published: 2025

Abstract

July 2025

View News titled, Phase II Results Point Toward a New Era in Treating Acute Myeloid Leukemia

1

About ASH Clinical News
Advertising
Subscribe

Contact Us

American Society of Hematology
2021 L Street NW, Suite 900
Washington, DC 20036
TEL +1 202-776-0544
FAX +1 202-776-0545

ASH Publications

Blood
Blood Advances
Blood Global Hematology
Blood Immunology & Cellular Therapy
Blood Neoplasia
Blood Red Cells & Iron
Blood Vessels, Thrombosis & Hemostasis
Hematology, ASH Education Program
ASH Clinical News
ASH-SAP
The Hematologist

American Society of Hematology

ASH Home
ASH Image Bank
ASH Store

Advocacy
Education
Meetings
Research

Copyright 2025 by American Society of Hematology

Cookie Settings
Privacy Policy
Cookie Policy
Terms of Use
Contact Us

This Feature Is Available To Subscribers Only

Sign In or Create an Account

Advertisement intended for health care professionals